Call 760-448-9500
IG-Case-Study2-1024x466-GS1

First pharmaceutical company to provide healthcare providers with RFID embedded smart labels at the dosage level. IntelliGuard is the first RFID company whose technology can read these medications.

Fresenius Kabi, a global healthcare company, launched an ambitious program and product portfolio called +RFID, becoming the first in its industry to tag vials of medication using RFID based on GS1 Standards.

Their goal was to support a safe, more efficient medication inventory process with ready-to-read data straight from the manufacturer. +RFID eliminates manual tagging and data entry, thus improving patient safety by reducing medical errors.

Using IntelliGuard technology in conjunction with the Fresenius Kabi +RFID portfolio further increases inventory accuracy, minimizes waste and decreases labor costs.

ANTICIPATED HOSPITAL BENEFITS:

  • Hospitals no longer need to apply their own RFID tags to pharmaceuticals.
  • Supplying the combination of the GTIN, serial number and tag ID, the RFID-labeled drug is virtually impossible to counterfeit, strengthening serialization already in place in compliance with the U.S. Food and Drug Administration (FDA) Drug Supply Chain Security Act1 (DSCSA).
  • In the event of a recall, the identity of target items can be pinpointed, with the item date, batch/lot, serial number or other related manufacturing details.
  • Hospitals can achieve more precise inventory management, with the ability to read many RFID tags in one scan versus individual item barcode scanning.

Download the detailed case study to read about how Fresenius Kabi, a global healthcare company, launched an ambitious program to support healthcare providers and become the first in its industry to tag vials of medication using an Electronic Product Code-enabled radio frequency identification (EPC/RFID) tagging system based on GS1 Standards.